Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2011-10-26 Interim / Quarterly Rep…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim report' for the period January-September 2011. It contains comprehensive financial statements, including consolidated statements of comprehensive income, balance sheet items, cash flow analysis, and management commentary on business performance. It is not a mere announcement or certification, as it provides substantive financial data for the specified period. Therefore, it fits the definition of an Interim/Quarterly Report (IR). 9M 2011
2011-10-26 English
Major Shareholding Notification 2011
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for Länsförsäkringar Fondförvaltning AB in Biotage AB. It explicitly states the 'Reason for major shareholding notification Buy' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of shares and voting rights (5.68%). This content directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ'. The document length is short (2888 chars), but the content is the notification itself, not an announcement of a report.
2011-10-04 English
Amerikanska patentverket ogiltigförklarar samtliga patentkrav i US patent 7,410,571 efter Biotages begäran om omprövning av giltigheten av desamma.
Legal Proceedings Report Classification · 98% confidence The document is a press release dated September 8, 2011, announcing a specific legal/regulatory outcome: the US Patent Office invalidated all claims in US patent 7,410,571 following a request for reexamination initiated by Biotage. This directly relates to ongoing patent infringement litigation mentioned in the text. This type of announcement concerning significant lawsuits or regulatory actions affecting the company's legal standing fits best under the 'Legal Proceedings Report' category (LTR). It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns a specific legal matter.
2011-09-08 Swedish
Following Biotage’s request for re-examination US Patent and Trademark Office has rejected all claims in US patent 7,410,571
Legal Proceedings Report Classification · 98% confidence The document is a press release from Biotage AB dated September 8, 2011, detailing the outcome of a patent re-examination process initiated due to a lawsuit filed by Scientific Plastic Products, Inc. The core subject matter is the rejection of claims in US patent 7,410,571 by the US Patent and Trademark Office, which relates to ongoing legal proceedings. This content directly addresses significant lawsuits and regulatory actions involving the company. According to the definitions, this fits best under 'Legal Proceedings Report' (LTR). It is not a financial report (10-K, IR, ER), a management change (MANG), or a general regulatory announcement (RNS), as it concerns a specific legal matter.
2011-09-08 English
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-June 2011. It contains comprehensive financial statements, including income statements, balance sheet summaries, cash flow analysis, and management commentary on business performance, risks, and outlook. It is clearly a substantive financial report for a period shorter than a full fiscal year, not an announcement or a certification, and exceeds the length requirements for a summary. H1 2011
2011-08-17 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report' and covers the period 'January - June 2011'. It contains comprehensive financial statements, including income statements, balance sheet items, cash flow analysis, and management commentary on business performance. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it fits the definition of an Interim/Quarterly Report (IR). H1 2011
2011-08-17 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.